Latest Updates
-
The Sepsis Clock: Why Waiting to See If the Fever Settles Can Be Dangerous -
Ganesh Chaturthi 2026: Inside The Star-Studded Celebrations At Lalbaugcha Raja And Antilia -
The 5-Minute Childhood Skincare Routine: Why Simpler May Actually Be Better -
OTT Releases This Week (September 14–20): What To Watch Across Netflix, Prime Video, JioHotstar And More -
Fiji's HIV Cases Have Risen 16-Fold Since 2019 — Now It's A National Emergency -
Can a 50-Year-Old Develop Alzheimer's? What Early-Onset Dementia Looks Like -
Mahalaxmi Vrat 2026: Date, Puja Vidhi, And The Legend Behind The 16 Knots -
Who Is Anant Nag? Meet The Veteran Kannada Actor Set To Receive Dadasaheb Phalke Award -
Monsoon And Diabetes: Why Infection Risk Increases During The Rainy Season -
Throwback Thursday: Kareena Kapoor’s ‘Poo’ To Priyanka Chopra’s ‘Desi Girl’, Bollywood Looks That Ruled 2000s
Mutant Protein
{image- www.boldsky.com} Researchers from Emory University have announced the development of an 'intrabody' tool that may help in wiping off the clusters of the mutant protein responsible for neurodegeneration in Huntington's disease.
They engineered a virus to make an intracellular antibody or "intrabody" against huntingtin, the protein whose mutant forms damage brain cells of people with Huntington's.
When they injected the virus into the mice's brains that make mutant huntingtin improved their ability to move their limbs, although it does not prolong their lives.
Xiao-Jiang Li, PhD, senior author and professor of human genetics at Emory University School of Medicine said that though other researchers have shown that various intrabodies can protect cells from mutant huntingtin, their team was the first to examine the effects of an intrabody in living mice.
"Our goal here was to create a tool that could distinguish between the accumulation of mutant proteins in the nucleus and the cytoplasm," he said.
"The intrabody binds huntingtin proteins with expanded poly-glutamine regions and it only works in the cytoplasm, not the nucleus."
Mutant proteins have a region consisting of the same amino acid (glutamine) many times, called poly-glutamine, which makes the proteins clump together inside brain cells.
The study showed that cultured cells that make both the intrabody and mutant huntingtin are able to get rid of the mutant protein faster and have fewer clumps of huntingtin.
"Several neurodegenerative diseases appear to involve defects in protein folding and metabolism, leading to the accumulation of protein aggregates inside cells," he said.
"Our study suggests a strategy for dissecting the harmful effects of these protein aggregates in other diseases," he added.
The study appears online and is scheduled for publication in the May/June issue of the Journal of Cell Biology.
Disclaimer: The information provided in this article is for general informational and educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or a qualified healthcare provider with any questions you may have regarding a medical condition.



Click it and Unblock the Notifications
